Sidi hong kong stock market time

Sidi Hong Kong Stock Exchange was listed on 2021116. As early as June 30th, 20021year, Sidi 3D Medicines Inc (referred to as "Sidi") from Shanghai submitted its prospectus to the Hong Kong Stock Exchange, preparing to be listed on the main board of Hong Kong. Established on 20 10, 3D Medicines focuses on the precise treatment of cancer, develops a business model of cancer diagnosis and treatment integration by integrating and mining the data of tumor biological characteristics, clinical diagnosis and treatment, drug research and development, and becomes a practitioner of cancer diagnosis and treatment integration in China. At present, it has more than 650 employees in China and the United States. Cooperate with more than 200 domestic third-class hospitals: in the field of peer diagnosis, provide complete integrated products and services for tumor diagnosis and treatment for different groups of people (including drug peer diagnosis and testing of tumor tissues and blood samples); In the field of tumor drug development, new anti-tumor drug research and development channels include immunotherapy and targeted therapy driven by other marker mutations. At present, the world's first new drug project of subcutaneous injection of anti-PD-L 1 tumor immunotherapy antibody has entered the global (China, the United States and Japan) synchronous clinical research and development stage.

1.Sidi diagnostic gene detection can be ranked in China?

At present, the main institutions for gene testing in China are: Sidi Diagnostics, Firestone Medicine, Huada Gene, berry and kang, Wuxi PharmaTech, Boao Bio, etc. Sidi Diagnostics is one of the leading medical testing companies in the industry, and it is also one of the earliest companies providing accurate medical testing services for tumors in China. They are more focused on the field of tumor detection. Moreover, tumor gene detection is entering a period of rapid development, which is the most potential application of gene detection and a field with market scale.

2. What are the top ten companies in domestic genetic testing?

The top ten companies in China are berry and kang, WuXi PharmaTech, Boao Bio, Daan Gene, Huayinkang, Carbon Cloud Intelligent, Zhongyuan Concord and Anno Road. The two better ones are BGI, a genetic testing institution under Shenzhen Huada Gene Technology Co., Ltd., which was established in 1999. It is engaged in the research and development of high-end instruments and genomes, ranking first among the top ten domestic genetic testing companies, and is mainly used in the fields of resource conservation, medical care and health, benefiting the general public. Berry and kang, Beijing berry and kang Biotechnology Co., Ltd. is a high-quality gene detection technology company, established on 20 10, which provides non-invasive solutions for clinical disease diagnosis and transforms gene sequencing technology into a pioneer in analyzing individual genomes and population genomes in clinical industry.